C. Antachopoulos, J. Meletiadis, T. Sein, E. Roilides, and T. Walsh, Concentration-Dependent Effects of Caspofungin on the Metabolic Activity of Aspergillus Species, Antimicrobial Agents and Chemotherapy, vol.51, issue.3, pp.881-887, 2007.
DOI : 10.1128/AAC.01160-06

C. Antachopoulos, J. Meletiadis, T. Sein, E. Roilides, and T. Walsh, Comparative In Vitro Pharmacodynamics of Caspofungin, Micafungin, and Anidulafungin against Germinated and Nongerminated Aspergillus Conidia, Antimicrobial Agents and Chemotherapy, vol.52, issue.1, pp.321-328, 2008.
DOI : 10.1128/AAC.00699-07

S. Arikan, M. Lozano-chiu, V. Paetznick, and J. Rex, In Vitro Susceptibility Testing Methods for Caspofungin against Aspergillus and Fusarium Isolates, Antimicrobial Agents and Chemotherapy, vol.45, issue.1, pp.327-330, 2001.
DOI : 10.1128/AAC.45.1.327-330.2001

URL : http://aac.asm.org/content/45/1/327.full.pdf

A. Beauvais, R. Drake, K. Ng, M. Diaquin, and J. Latge, Characterization of the 1,3-??-glucan synthase of Aspergillus fumigatus, Journal of General Microbiology, vol.139, issue.12, pp.3071-3078, 1993.
DOI : 10.1099/00221287-139-12-3071

A. Beauvais, Two ??(1-3) Glucan Synthases with Different Functions in Aspergillus fumigatus, Applied and Environmental Microbiology, vol.71, issue.3, pp.1531-1538, 2005.
DOI : 10.1128/AEM.71.3.1531-1538.2005

R. Ben-ami, R. Lewis, and D. Kontoyiannis, : lack of concordance among methods, Medical Mycology, vol.49, issue.3, pp.285-288, 2011.
DOI : 10.1097/01.tp.0000202421.94822.f7

J. Bowman, The Antifungal Echinocandin Caspofungin Acetate Kills Growing Cells of Aspergillus fumigatus In Vitro, Antimicrobial Agents and Chemotherapy, vol.46, issue.9, pp.3001-3012, 2002.
DOI : 10.1128/AAC.46.9.3001-3012.2002

E. Chryssanthou and M. Cuenca-estrella, Comparison of the EUCAST-AFST broth dilution method with the CLSI reference broth dilution method (M38-A) for susceptibility testing of posaconazole and voriconazole against Aspergillus spp., Clinical Microbiology and Infection, vol.12, issue.9, pp.901-904, 2006.
DOI : 10.1111/j.1469-0691.2006.01419.x

J. Fortwendel, Differential Effects of Inhibiting Chitin and 1,3-??-D-Glucan Synthesis in Ras and Calcineurin Mutants of Aspergillus fumigatus, Antimicrobial Agents and Chemotherapy, vol.53, issue.2, pp.476-482, 2009.
DOI : 10.1128/AAC.01154-08

M. Kurtz, Morphological effects of lipopeptides against Aspergillus fumigatus correlate with activities against (1,3)-beta-D-glucan synthase., Antimicrobial Agents and Chemotherapy, vol.38, issue.7, pp.1480-1489, 1994.
DOI : 10.1128/AAC.38.7.1480

R. Lewis, N. Albert, and D. Kontoyiannis, Comparison of the dose-dependent activity and paradoxical effect of caspofungin and micafungin in a neutropenic murine model of invasive pulmonary aspergillosis, Journal of Antimicrobial Chemotherapy, vol.61, issue.5, pp.1140-1144, 2008.
DOI : 10.1093/jac/dkn069

I. Mouyna, Members of protein O-mannosyltransferase family in Aspergillus fumigatus differentially affect growth, morphogenesis and viability, Molecular Microbiology, vol.6, issue.5, pp.1205-1221, 2010.
DOI : 10.1016/S0304-4165(98)00131-7

URL : https://hal.archives-ouvertes.fr/pasteur-01709241

E. Rocha, G. Garcia-effron, S. Park, and D. Perlin, A Ser678Pro Substitution in Fks1p Confers Resistance to Echinocandin Drugs in Aspergillus fumigatus, Antimicrobial Agents and Chemotherapy, vol.51, issue.11, pp.4174-4176, 2007.
DOI : 10.1128/AAC.00917-07

T. Dorsthorst, D. Zwaaftink, R. Rijs, A. Meletiadis, J. Verweij et al., species against caspofungin, Medical Mycology, vol.38, issue.4, pp.351-355, 2007.
DOI : 10.1128/JCM.39.7.2738-2741.2001

A. Tortorano, A Multicenter Study, Journal of Chemotherapy, vol.42, issue.3, pp.246-252, 2002.
DOI : 10.1053/jinf.2000.0747

H. Yamaguchi, K. Uchida, K. Nagino, and T. Matsunaga, Usefulness of a colorimetric method for testing antifungal drug susceptibilities of Aspergillus species to voriconazole, Journal of Infection and Chemotherapy, vol.8, issue.4, pp.374-377, 2002.
DOI : 10.1007/s10156-002-0201-Y